ISRCTN51170824进行中(未招募)未知
Peri-transplAnt InsuliN Therapy to improve outcomes after pancrEas tRansplantation (PAINTER): an open label randomised clinical trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All patients undergoing simultaneous pancreas and kidney transplantation will be considered eligible for inclusion in the trial. Eligibility for pancreas transplantation is outlined in the NHSBT Organ Donation and Transplantation Pancreas Selection Policy.
排除标准
- •1. Aged <18 years or >65 years
- •2. Inability to self-consent
- •3. Pancreas transplant alone after previous kidney or pancreas transplantation
研究者
相似试验
已完成
不适用
Improving insulin treatmentutritional, Metabolic, Endocrine: DiabetesNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusISRCTN79558333Department of Health30
已完成
不适用
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes MellitusLipohypertrophyDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1NCT04120974Becton, Dickinson and Company90
招募中
不适用
The effective switch from intensive insulin therapy to the once-daily human GLP-1 analogue liraglutide in patients with fairly well controlled type 2 diabetestype 2 diabetesJPRN-UMIN000005202Department of Diabetes and Endocrinology, Kanto Rosai Hospital20
已完成
不适用
perioperative intensive insulin therapy by continuous glucose monitoring systemhyperglycemiaJPRN-UMIN000028251Tokushima University50
已完成
不适用
The Effect of Intensive Insulin Therapy in the Surgical Critical Care UnitSurgical Site InfectionSepsisRespiratory FailureRenal FailureNCT00282594Genesys317
